Trial intelligence / Profile preview

Sandostatin LAR for chemotherapy-induced diarrhea

NCT00050635Phase 4Completed

Sponsor
Novartis
Start
Dec 2002
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of octreotide in diarrhea, sponsored by Novartis. Started Dec 2002; status: completed.

02

Drugs

octreotide
03

Conditions

diarrhea

Beyond the preview

Go deeper on NCT00050635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00050635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call